{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:15:59Z","timestamp":1793164559953,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ekir.2021.01.021","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T11:16:16Z","timestamp":1611918976000},"page":"1015-1021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis\u2013Induced Thrombotic Microangiopathies"],"prefix":"10.1016","volume":"6","author":[{"given":"Anna","family":"Gouin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ribes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Colombat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Chauveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregoire","family":"Prevot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lairez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Pugnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Fremeaux-Bacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Huart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Belliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas","family":"Faguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2021.01.021_bib1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2021.01.021_bib2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome","volume":"390","author":"Fakhouri","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2021.01.021_bib3","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.kint.2019.01.023","article-title":"Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors","volume":"95","author":"Le Clech","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2021.01.021_bib4","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/annrheumdis-2020-217058","article-title":"Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: Results of a long-term follow-up multicentre study","volume":"79","author":"Van Bijnen","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ekir.2021.01.021_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/BOR.0000000000000432","article-title":"Biologics for idiopathic inflammatory myopathies","volume":"29","author":"Moghadam-Kia","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ekir.2021.01.021_bib6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O\u2019Callaghan","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ekir.2021.01.021_bib7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2215\/CJN.11470918","article-title":"Etiology and outcomes of thrombotic microangiopathies","volume":"14","author":"Bayer","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2021.01.021_bib8","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrneph.2016.124","article-title":"Scleroderma renal crisis and renal involvement in systemic sclerosis","volume":"12","author":"Woodworth","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2021.01.021_bib9","doi-asserted-by":"crossref","first-page":"6051083","DOI":"10.1155\/2018\/6051083","article-title":"Scleroderma renal crisis debute with thrombotic microangiopathy: a successful case treated with eculizumab","volume":"2018","author":"Uriarte","year":"2018","journal-title":"Case Reports Nephrol"},{"key":"10.1016\/j.ekir.2021.01.021_bib10","doi-asserted-by":"crossref","first-page":"e4459","DOI":"10.1097\/MD.0000000000004459","article-title":"Complement activation and effect of eculizumab in scleroderma renal crisis","volume":"95","author":"Devresse","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ekir.2021.01.021_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13075-016-1168-x","article-title":"Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis","volume":"18","author":"Okr\u00f3j","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ekir.2021.01.021_bib12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF02918260","article-title":"The complement system and systemic sclerosis","volume":"12","author":"Benbassat","year":"1993","journal-title":"Immunol Res"},{"key":"10.1016\/j.ekir.2021.01.021_bib13","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.3899\/jrheum.180060","article-title":"Complement c5-blocking agent in refractory dermatomyositis","volume":"45","author":"Faguer","year":"2018","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ekir.2021.01.021_bib14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ckj\/sfw072","article-title":"Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome","volume":"9","author":"Cianciolo","year":"2016","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2021.01.021_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2016.11.012","article-title":"Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and Klotho","volume":"100","author":"Yamada","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.ekir.2021.01.021_bib16","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.2169\/internalmedicine.0512-17","article-title":"Thrombotic microangiopathy with polymyositis\/dermatomyositis: three case reports and a literature review","volume":"57","author":"Yamada","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.ekir.2021.01.021_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1160\/TH08-12-0825","article-title":"Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases","volume":"102","author":"Matsuyama","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ekir.2021.01.021_bib18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","article-title":"Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis: A Randomized, Placebo-phase Trial","volume":"65","author":"Oddis","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ekir.2021.01.021_bib19","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/brain\/aww122","article-title":"Microvascular alterations and the role of complement in dermatomyositis","volume":"139","author":"Lahoria","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.ekir.2021.01.021_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MD.0000000000000015","article-title":"The spectrum of renal involvement in patients with inflammatory myopathies","volume":"93","author":"Couvrat-Desvergnes","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ekir.2021.01.021_bib21","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/rheumatology\/kez435","article-title":"Review Classifications of scleroderma renal crisis and reconsideration of its pathophysiology","volume":"58","author":"Yamashita","year":"2019","journal-title":"Rheumatology (Oxford)"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024921000243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024921000243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:35:16Z","timestamp":1762832116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024921000243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2468024921000243"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2021.01.021","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis\u2013Induced Thrombotic Microangiopathies","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2021.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}